Andrew C Dietz1, Yan Chen2, Yutaka Yasui3, Kirsten K Ness3, James S Hagood4, Eric J Chow5, Marilyn Stovall6, Joseph P Neglia7, Kevin C Oeffinger8, Ann C Mertens9, Leslie L Robison3, Gregory T Armstrong3, Daniel A Mulrooney3. 1. Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California. 2. Department of Public Health Science, University of Alberta, Edmonton, Alberta, Canada. 3. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee. 4. Department of Pediatrics, Rady Children's Hospital, San Diego, California. 5. Fred Hutchinson Cancer Research Center, Seattle, Washington. 6. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas. 7. Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota. 8. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. 9. Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia.
Abstract
BACKGROUND: Pulmonary complications after cancer therapy are varied. This study describes pulmonary outcomes among childhood cancer survivors and evaluates their impact on daily activities. METHODS: The incidence of pulmonary outcomes (asthma, chronic cough, emphysema, lung fibrosis, oxygen need, and recurrent pneumonia) reported among 5-year cancer survivors (n = 14,316) and the incidence of death due to pulmonary causes among all eligible survivors (n = 20,690) in the Childhood Cancer Survivor Study were compared with those for sibling controls (n = 4027) with cumulative incidence, standardized mortality ratio (SMR), and piecewise exponential models. Logistic regression with random effects was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for activity limitations with pulmonary complications. RESULTS: By the age of 45 years, the cumulative incidence of any pulmonary condition was 29.6% (95% CI, 29.1%-30.0%) for cancer survivors and 26.5% (95% CI, 24.9%-28.0%) for siblings. Fewer survivors reported ever smoking (23.6% vs 36.4%, P < .001), but survivors were more likely to report chronic cough (rate ratio [RR], 1.6; 95% CI, 1.4-1.9), oxygen need (RR, 1.8; 95% CI, 1.5-2.2), lung fibrosis (RR, 3.5; 95% CI, 2.3-5.4), and recurrent pneumonia (RR, 2.0; 95% CI, 1.4-3.0). The SMR for death due to pulmonary causes was 5.9 (95% CI, 4.2-8.1), and it was associated with platinum exposure and lung radiation (P < .01). The impact of chronic cough on daily activities for survivors (OR vs survivors without chronic cough, 2.7) was greater than that for siblings (OR, 2.0; P = .04). CONCLUSIONS: Pulmonary complications are substantial among adult survivors of childhood cancer and can affect daily activities. Cancer 2016;122:3687-96.
BACKGROUND:Pulmonary complications after cancer therapy are varied. This study describes pulmonary outcomes among childhood cancer survivors and evaluates their impact on daily activities. METHODS: The incidence of pulmonary outcomes (asthma, chronic cough, emphysema, lung fibrosis, oxygen need, and recurrent pneumonia) reported among 5-year cancer survivors (n = 14,316) and the incidence of death due to pulmonary causes among all eligible survivors (n = 20,690) in the Childhood Cancer Survivor Study were compared with those for sibling controls (n = 4027) with cumulative incidence, standardized mortality ratio (SMR), and piecewise exponential models. Logistic regression with random effects was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for activity limitations with pulmonary complications. RESULTS: By the age of 45 years, the cumulative incidence of any pulmonary condition was 29.6% (95% CI, 29.1%-30.0%) for cancer survivors and 26.5% (95% CI, 24.9%-28.0%) for siblings. Fewer survivors reported ever smoking (23.6% vs 36.4%, P < .001), but survivors were more likely to report chronic cough (rate ratio [RR], 1.6; 95% CI, 1.4-1.9), oxygen need (RR, 1.8; 95% CI, 1.5-2.2), lung fibrosis (RR, 3.5; 95% CI, 2.3-5.4), and recurrent pneumonia (RR, 2.0; 95% CI, 1.4-3.0). The SMR for death due to pulmonary causes was 5.9 (95% CI, 4.2-8.1), and it was associated with platinum exposure and lung radiation (P < .01). The impact of chronic cough on daily activities for survivors (OR vs survivors without chronic cough, 2.7) was greater than that for siblings (OR, 2.0; P = .04). CONCLUSIONS:Pulmonary complications are substantial among adult survivors of childhood cancer and can affect daily activities. Cancer 2016;122:3687-96.
Authors: Wendy M Leisenring; Ann C Mertens; Gregory T Armstrong; Marilyn A Stovall; Joseph P Neglia; Jennifer Q Lanctot; John D Boice; John A Whitton; Yutaka Yasui Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544
Authors: Tseng-Tien Huang; Melissa M Hudson; Dennis C Stokes; Matthew J Krasin; Sheri L Spunt; Kirsten K Ness Journal: Chest Date: 2011-03-17 Impact factor: 9.410
Authors: Kirsten K Ness; E Brannon Morris; Vikki G Nolan; Carrie R Howell; Laura S Gilchrist; Marilyn Stovall; Cheryl L Cox; James L Klosky; Amar Gajjar; Joseph P Neglia Journal: Cancer Date: 2010-06-15 Impact factor: 6.860
Authors: N M Marina; C A Greenwald; D L Fairclough; E I Thompson; J A Wilimas; P W Mackert; M M Hudson; D C Stokes; P M Bozeman Journal: Cancer Date: 1995-04-01 Impact factor: 6.860
Authors: Ann C Mertens; Yutaka Yasui; Yan Liu; Marilyn Stovall; Ray Hutchinson; Jill Ginsberg; Charles Sklar; Leslie L Robison Journal: Cancer Date: 2002-12-01 Impact factor: 6.921
Authors: Anne Stone; Danielle Novetsky Friedman; Brian H Kushner; Suzanne Wolden; Shakeel Modak; Michael P LaQuaglia; Jessica Costello; Xian Wu; Nai-Kong Cheung; Charles A Sklar Journal: Pediatr Blood Cancer Date: 2019-08-12 Impact factor: 3.167
Authors: Anne Stone; Danielle Novetsky Friedman; Stefan Worgall; Brian H Kushner; Suzanne Wolden; Shakeel Modak; Michael P LaQuaglia; Xian Wu; Nai-Kong Cheung; Charles A Sklar Journal: J Pediatr Hematol Oncol Date: 2017-10 Impact factor: 1.289
Authors: HaiThuy N Nguyen; Shailendra Das; Maria C Gazzaneo; Ernestina Melicoff; George B Mallory; Karen W Eldin; R Paul Guillerman Journal: Pediatr Radiol Date: 2019-04-19
Authors: Daniel A Mulrooney; Yutaka Yasui; Cindy Im; Yan Yuan; Eric D Austin; Dennis C Stokes; Matthew J Krasin; Andrew M Davidoff; Yadav Sapkota; Zhaoming Wang; Kirsten K Ness; Carmen L Wilson; Gregory T Armstrong; Melissa M Hudson; Leslie L Robison Journal: Cancer Res Date: 2022-08-16 Impact factor: 13.312
Authors: Sara J Schonfeld; Rebecca M Howell; Susan A Smith; Joseph P Neglia; Lucie M Turcotte; Michael A Arnold; Peter D Inskip; Kevin C Oeffinger; Chaya S Moskowitz; Tara O Henderson; Wendy M Leisenring; Todd M Gibson; Amy Berrington de González; Joshua N Sampson; Stephen J Chanock; Margaret A Tucker; Smita Bhatia; Leslie L Robison; Gregory T Armstrong; Lindsay M Morton Journal: Radiat Res Date: 2019-12-03 Impact factor: 2.841
Authors: Andrew C Dietz; Kristy Seidel; Wendy M Leisenring; Daniel A Mulrooney; Jean M Tersak; Richard D Glick; Cathy A Burnweit; Daniel M Green; Lisa R Diller; Susan A Smith; Rebecca M Howell; Marilyn Stovall; Gregory T Armstrong; Kevin C Oeffinger; Leslie L Robison; Amanda M Termuhlen Journal: Lancet Oncol Date: 2019-08-27 Impact factor: 41.316
Authors: Maria Otth; Christina Schindera; Tayfun Güngör; Marc Ansari; Katrin Scheinemann; Fabiën N Belle; Philipp Latzin; Nicolas von der Weid; Claudia E Kuehni Journal: Bone Marrow Transplant Date: 2020-11-25 Impact factor: 5.483
Authors: Yevgeniy Vinogradskiy; Austin Faught; Richard Castillo; Edward Castillo; Thomas Guerrero; Moyed Miften; Arthur K Liu Journal: J Appl Clin Med Phys Date: 2018-06-26 Impact factor: 2.102